A real-world experience of nivolumab in advanced malignant mesothelioma (MM).

被引：3
|
作者：
Hamad, Hussein [1 ]
Shafi, Sumaira [1 ]
De Rosen, Veronica Lenge [1 ]
Zhang, Jun [1 ]
机构：
[1] Baylor Coll Med, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.8569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8569
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nivolumab for Malignant Mesothelioma: A Real-World Experience
    Niki, M.
    Yokoi, T.
    Takahashi, R.
    Mikami, K.
    Shibata, E.
    Nakajima, Y.
    Negi, Y.
    Ishigaki, H.
    Tada, A.
    Higashiyama, T.
    Kamei, T.
    Minami, T.
    Kuribayashi, K.
    Kijima, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S758 - S758
  • [2] Real-world outcomes with nivolumab for pre-treated malignant mesothelioma in the UK
    Morton, Cienne
    Gennatas, Spyridon
    Holden, Sophia
    Karapanagiotou, Eleni
    Spicer, James
    Georgiou, Alexandros
    [J]. LUNG CANCER, 2022, 165 : S27 - S27
  • [3] Real-world treatment for malignant pleural mesothelioma: the Belgian experience
    Rosskamp, M.
    Van Damme, N.
    De Schutter, H.
    Slabbaert, M.
    Henau, K.
    Praet, M.
    Nackaerts, K.
    Van Meerbeeck, J. P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 72 : S177 - S178
  • [4] Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma
    Dumoulin, D. W.
    Douma, L. H.
    Hofman, M. M.
    van der Noort, V.
    Cornelissen, R.
    de Gooijer, C. J.
    Burgers, J. A.
    Aerts, J. G. J. V.
    [J]. LUNG CANCER, 2024, 187
  • [5] Immunotherapy Toxicities in Real-World Use of Nivolumab & Ipilimumab in Pleural Malignant Mesothelioma: Experience from Sussex Cancer Centre
    Lonn, Cheung
    Zaki, Kam
    Donovan, Victoria
    Kanlal, Kavita
    [J]. LUNG CANCER, 2024, 190
  • [6] Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients
    Holzknecht, Arnulf
    Illini, Oliver
    Hochmair, Maximilian J.
    Krenbek, Dagmar
    Setinek, Ulrike
    Huemer, Florian
    Bitterlich, Erwin
    Kaindl, Christoph
    Getman, Vladyslav
    Akan, Ahmet
    Weber, Michael
    Leobacher, Gunther
    Valipour, Arschang
    Mueller, Michael R.
    Watzka, Stefan B.
    [J]. CANCERS, 2022, 14 (09)
  • [7] Nivolumab in Recurrent Malignant Pleural Mesothelioma: Real-World Data From Expanded Access Program In The Netherlands
    Belderbos, R.
    Cantini, L.
    Gooijer, C.
    Dumoulin, D.
    Cornelissen, R.
    Burgers, S.
    Baas, P.
    Aerts, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S123 - S123
  • [8] Real-world experience of combined ipilimumab and nivolumab for advanced melanoma in a single UK institution
    Boon, Ian S.
    Marples, Maria
    [J]. CLINICAL ONCOLOGY, 2018, 30 : E2 - E2
  • [9] Real-world experience with nivolumab and atezolizumab toxicities in advanced thoracic malignancies: a single centre experience in the UK
    Choy, J.
    Chang, Y.
    Newsom-Davis, T.
    [J]. LUNG CANCER, 2019, 127 : S69 - S70
  • [10] Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance study
    Fujimoto, Nobukazu
    Akamatsu, Ayumi
    Honda, Chikara
    Aoki, Miki
    Ohe, Yuichiro
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024,
12345